May 7, 2019 Bio/Pharma/CRO Licensing, IP, and Legal

A wholly-owned subsidiary, Takara Biotechnology (Dalian) Co., Ltd. Acquires ISO:13485 certification

2019/05/07 Kusatsu/Shiga, Japan – April 24, 2019 –  Takara Bio Inc. (Takara Bio) announced that Takara Biotechnology (Dalian) Co., Ltd. (Dalian city, China, hereafter “Takara Biotechnology (Dalian)”), a wholly-owned subsidiary of Takara Bio has acquired ISO 13485:2016 certification, an international standard for quality management system of medical devices and diagnostic pharmaceuticals.   Takara Biotechnology (Dalian) is a... Read more

April 30, 2019 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

BD Receives FDA Approval for Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

FRANKLIN LAKES, N.J., April 30, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep™ skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the... Read more

April 22, 2019 Bio/Pharma/CRO Clinical Research/Diagn. M&A, Partnerships

Elpiscience and Bio-Techne Announce Strategic Collaboration

APRIL 22, 2019 SHANGHAI and MINNEAPOLIS, April 22, 2019 /PRNewswire/ — Elpiscience BioPharma and Bio-Techne Corporation announced today that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the terms of the agreement, Elpiscience will have access to multiple antibodies from Bio-Techne’s extensive product portfolio for use in the development of preclinical, clinical, and commercial... Read more

April 17, 2019 Bio/Pharma/CRO Product Launch

Jackson ImmunoResearch launches Secondary Antibodies for VHH discovery

West Grove, PA – April 17, 2019 – Jackson ImmunoResearch, manufacturer of secondary antibodies for the life science market, announces a new range of products for scientists developing single-domain VHH antibodies.The new Anti-Alpaca secondary antibody product line targets the IgG repertoire of camelid immunoglobulins, including whole molecule, subclass and VHH domain specificities. They are raised against... Read more

April 17, 2019 Acad, Gov/Utilities Bio/Pharma/CRO Chromatography Clinical Research/Diagn. Lab Top-10 PR/Corporate

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., April 16, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has... Read more

April 16, 2019 Atomic Spectroscopy Bio/Pharma/CRO Lab Top-10 Microscopy

PerkinElmer Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research

Announcement at 2019 Bio-IT World Conference & Expo syncs with PerkinElmer’s strategy to get labs from big data overload to research insights faster and easier WALTHAM, Massachusetts – April 16, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has joined Accenture’s open partner ecosystem, designed... Read more

April 8, 2019 Bio/Pharma/CRO Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Announces Collaboration to Advance Biopharmaceutical Characterization and Monitoring Methods

Thermo Fisher Scientific Announces Collaboration to Advance Biopharmaceutical Characterization and Monitoring Methods Thermo Fisher and Genovis to develop advanced end-to-end workflows for biotherapeutics analysis SUNNYVALE, Calif., April 8, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Genovis, a leading provider of enzyme products for biological drug development, begin a collaborative research... Read more

April 8, 2019 Bio/Pharma/CRO Product Launch

BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion

FRANKLIN LAKES, N.J., April 8, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global availability of BD BACTEC™ platelet quality control media, which allows microbiology laboratories, blood banks and transfusion services to identify contaminated platelet units.   An estimated 12 million apheresis platelet donations are... Read more

April 7, 2019 Bio/Pharma/CRO Informatics & Software Lab Top-10

Bruker Introduces NMR Research and Pharma Innovations at ENC 2019

ASILOMAR, California – April 7, 2019 – At ENC 2019, Bruker highlights innovative NMR capabilities and products for biomolecular, materials research and pharmaceutical applications, as well as new scientific software solutions. Dr. Falko Busse, Bruker BioSpin’s Group President, stated: “Our new NMR instruments and solutions at ENC 2019 demonstrate the diversity and flexibility that Bruker brings... Read more

April 2, 2019 Bio/Pharma/CRO Lab Top-10 Life Science Tools Product Launch

Agilent Introduces New System for RNA and DNA Quality Control Laboratories

Agilent Introduces New System for RNA and DNA Quality Control Laboratories Instrument provides automated electrophoresis for labs with limited budgets SANTA CLARA, Calif., April 02, 2019 Agilent Technologies, Inc. (NYSE: A) announced today the shipping of a new instrument that offers laboratories a more affordable, low-throughput option for analyzing the quality of RNA and DNA... Read more